Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.
Gevo (NASDAQ:GEVO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have ...
Palantir Technologies (NASDAQ:PLTR – Get Free Report) had its price objective increased by research analysts at DA Davidson from $47.00 to $105.00 in a note issued to investors on Tuesday,Benzinga ...
Investors and other persons interested in learning more about the virtual investor presentation can find information and registration details at the following link: About Gevo Gevo is a ...
The blue-chip index, up 0.6%, was heading for its second consecutive gain this week. The Dow was riding higher on gains in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results